BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19412184)

  • 1. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway.
    Palsson-McDermott EM; Doyle SL; McGettrick AF; Hardy M; Husebye H; Banahan K; Gong M; Golenbock D; Espevik T; O'Neill LA
    Nat Immunol; 2009 Jun; 10(6):579-86. PubMed ID: 19412184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation.
    Doyle SL; Husebye H; Connolly DJ; Espevik T; O'Neill LA; McGettrick AF
    Nat Commun; 2012 Feb; 3():707. PubMed ID: 22426228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
    Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
    J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
    Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
    J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
    Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
    J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.
    Yurchenko M; Skjesol A; Ryan L; Richard GM; Kandasamy RK; Wang N; Terhorst C; Husebye H; Espevik T
    J Cell Biol; 2018 Apr; 217(4):1411-1429. PubMed ID: 29440514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD14, TLR4 and TRAM Show Different Trafficking Dynamics During LPS Stimulation.
    Klein DC; Skjesol A; Kers-Rebel ED; Sherstova T; Sporsheim B; Egeberg KW; Stokke BT; Espevik T; Husebye H
    Traffic; 2015 Jul; 16(7):677-90. PubMed ID: 25707286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling.
    Tanimura N; Saitoh S; Matsumoto F; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 368(1):94-9. PubMed ID: 18222170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling.
    Van Acker T; Eyckerman S; Vande Walle L; Gerlo S; Goethals M; Lamkanfi M; Bovijn C; Tavernier J; Peelman F
    J Biol Chem; 2014 Jan; 289(3):1364-76. PubMed ID: 24297182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase PTPN4 preferentially inhibits TRIF-dependent TLR4 pathway by dephosphorylating TRAM.
    Huai W; Song H; Wang L; Li B; Zhao J; Han L; Gao C; Jiang G; Zhang L; Zhao W
    J Immunol; 2015 May; 194(9):4458-65. PubMed ID: 25825441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signaling pathway.
    Wang Y; Yang Y; Liu X; Wang N; Cao H; Lu Y; Zhou H; Zheng J
    Cell Immunol; 2012; 274(1-2):121-9. PubMed ID: 22341560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
    Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
    PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling.
    Naiki Y; Michelsen KS; Zhang W; Chen S; Doherty TM; Arditi M
    J Biol Chem; 2005 Feb; 280(7):5491-5. PubMed ID: 15623538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling.
    Funami K; Matsumoto M; Oshiumi H; Inagaki F; Seya T
    Biochem Soc Trans; 2017 Aug; 45(4):929-935. PubMed ID: 28630139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
    Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
    Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4.
    Wang Y; Chen T; Han C; He D; Liu H; An H; Cai Z; Cao X
    Blood; 2007 Aug; 110(3):962-71. PubMed ID: 17395780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TIR-domain containing adaptor TRAM is required for TLR7 mediated RANTES production.
    Shevlin E; Miggin SM
    PLoS One; 2014; 9(9):e107141. PubMed ID: 25211222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.